068330 — Ilshinbiobase Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapContrarian

Annual balance sheet for Ilshinbiobase Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	ARS/A	ARS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	20,152	25,577	27,712	33,493	37,236
Net Total Accounts Receivable
Net Total Receivables	4,633	4,251	4,322	2,714	1,898
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	32,018	38,171	41,175	46,528	49,822
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	11,218	10,842	10,698	10,433	9,993
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	49,548	56,439	58,451	60,618	63,940
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	4,758	5,950	4,425	3,445	3,456
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	5,169	6,359	4,632	3,554	3,490
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	44,379	50,080	53,819	57,064	60,450
Total Liabilities & Shareholders' Equity	49,548	56,439	58,451	60,618	63,940
Total Common Shares Outstanding